Natumin Pharma AB is a Swedish biotech and pharmaceutical company founded in 1995. The company specializes in developing unique products based on innovative ingredients with a focus on extensive research. Natumin Pharma aims to enhance the quality of life through superior products catering to various aspects of human well-being. Their product range spans from food supplements, Traditional Herbal Medicinals, Medical Devices, cosmeceuticals, to a wide array of skin care products, targeting the global market through strategic distribution partnerships. The Research and Development department serves as the cornerstone of the company, emphasizing teamwork, accountability, and a streamlined decision-making process. Natumin Pharma prides itself on maintaining control over production quality by manufacturing products in their own GMP-certified production plant. Additionally, the company offers sub-contract product development and manufacturing services. With a focus on innovation, extensive research, and a diverse product portfolio, Natumin Pharma AB presents an intriguing opportunity for investors seeking involvement in the biotechnology and pharmaceutical industries. While details about the company's recent investment and investors are not available, the company's long-standing presence and commitment to quality make it a potential prospect for investment consideration.
There is no investment information
No recent news or press coverage available for Natumin Pharma AB.